97 related articles for article (PubMed ID: 19134234)
1. Markov modelling of HIV infection evolution in the HAART era.
Binquet C; Le Teuff G; Abrahamovicz M; Mahboubi A; Yazdanpanah Y; Rey D; Rabaud C; Chirouze C; Berger JL; Faller JP; Chavanet P; Quantin C; Piroth L;
Epidemiol Infect; 2009 Sep; 137(9):1272-82. PubMed ID: 19134234
[TBL] [Abstract][Full Text] [Related]
2. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
3. A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients.
Piroth L; Fournel I; Mahy S; Yazdanpanah Y; Rey D; Rabaud C; Faller JP; Hoen B; Fardeheb M; Quantin C; Chavanet P; Binquet C;
Epidemiol Infect; 2011 Dec; 139(12):1835-44. PubMed ID: 21232172
[TBL] [Abstract][Full Text] [Related]
4. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
9. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
[TBL] [Abstract][Full Text] [Related]
10. Immunological responses during a virologically failing antiretroviral regimen are associated with in vivo synonymous mutation rates of HIV type-1 env.
Mens H; Jørgensen LB; Kronborg G; Schønning K; Benfield T
Antivir Ther; 2009; 14(3):413-22. PubMed ID: 19474475
[TBL] [Abstract][Full Text] [Related]
11. [Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status].
Rodríguez de Schiavi MS; Scrigni A; García Arrigoni P; Bologna R; Barboni G; Redondo J; Nastri M; Mecikovsky D; Cantisano C; Moreno R; Siciliani D; Lencina M; Luedicke N; Rezzónico G; Torolla JL; López Papucci S; Luis M; Libonati C; Gamba L; Barbarysky J; Pérez Hernández E; Zlatkes R
Arch Argent Pediatr; 2009 Jun; 107(3):212-20. PubMed ID: 19543629
[TBL] [Abstract][Full Text] [Related]
12. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
13. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
[TBL] [Abstract][Full Text] [Related]
14. Impact of depression on HIV outcomes in the HAART era.
Hartzell JD; Janke IE; Weintrob AC
J Antimicrob Chemother; 2008 Aug; 62(2):246-55. PubMed ID: 18456650
[TBL] [Abstract][Full Text] [Related]
15. Changes in HIV-related hospitalizations during the HAART era in an inner-city hospital.
Pulvirenti J; Muppidi U; Glowacki R; Cristofano M; Baker L
AIDS Read; 2007 Aug; 17(8):390-4, 397-401. PubMed ID: 17717882
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
17. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
[TBL] [Abstract][Full Text] [Related]
18. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.
Gazzola L; Tincati C; Bellistrì GM; Monforte Ad; Marchetti G
Clin Infect Dis; 2009 Feb; 48(3):328-37. PubMed ID: 19123868
[TBL] [Abstract][Full Text] [Related]
19. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
20. Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.
Bonora S; Nicastri E; Calcagno A; Gonzalez de Requena D; D'Ettorre G; Sarmati L; Palmisano L; Vullo V; Di Perri G; Andreoni M
J Med Virol; 2009 Mar; 81(3):400-5. PubMed ID: 19152404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
